|
I.A. Ilovayskaya, P.A. Zakharova, E.D. Metlushko
Monitoring of patients with acromegaly in the real-life clinical practice settings
|
№11-12 / 2022
|
|
A.E. Goldshmid (1), E.Yu. Martynova (1), Yu.E. Poteshkin (2)
Clinical case of the use of the long-acting somatostatin analogue in a patient with acromegaly who has not achieved clinical and laboratory remission after telegrammatherapy
|
№4 / 2019
|
|
S.V. Mishugin, A.A. Mordovin, A.A. Gritskevich, I.G. Rusakov
EXPERIENCE OF THE USE OF OCTREOTIDE IN THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER
|
№8 / 2015
|
|
M.B. Antsiferov (1), V.S. Pronin (2)
OPTIMIZATION OF TREATMENT OF PATIENTS WITH ACROMEGALY: INCREASE THE INTERVAL BETWEEN INJECTIONS OF LANREOTIDE
|
№16 / 2014
|
|
A.V. Kalinin
NEUROENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT AND PANCREAS AS GASTROENTEROLOGICAL A PROBLEM
|
№14 / 2013
|
|
M.B. Antciferov, V.S. Pronin, T.M. Alekseeva
Drug Treatment Of Patients With Acromegaly, Partially Resistant To Therapy With Somatostatin Analogs
|
№16 / 2011
|
|
V.Pronin, Y.Poteshkin С. 6467
Use Of Somastatin Analogues In The Treatment Of Patients With Acromegaly: Options For The Drug Somatuline® Autogel® Use
|
№3 / 2010
|
|
I.A. Ilovayskaya С. 2531
Cardiologic Complications Of Acromegaly
|
№10 / 2009
|
|
A.V. Egorov, I.A. Vasilyev
Diagnostics And Treatment Of Neuroendocrine Tumors Of Abdominal Cavity And Retroperitoneal Space (review Of Literature)
|
№2 / 2009
|
Русский
